Heart Test Laboratories is a medical technology company focused on applying artificial intelligence-based technology to an electrocardiogram (ECG). Co.'s primary product candidate, the MyoVista wavECG (the MyoVista), is a resting 12-lead ECG that can be used in a range of clinical settings and provides diagnostic information related to cardiac dysfunction to healthcare professional, which has only been available through the use of cardiac imaging. The MyoVista also provides conventional ECG information in the same test. The HSCS average annual return since 2022 is shown above.
The Average Annual Return on the HSCS average annual return since 2022 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether HSCS average annual return since 2022 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the HSCS average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|